Home  »  Company  »  Ajanta Pharma Ltd.  »  Quotes  »  Company History
Enter the first few characters of Company and click 'Go'

Ajanta Pharma Ltd. Company History and Annual Growth Details

2005
-Max Healthcare to establish India`s first brain lab in New Delhi
-Max India Ltd Max telecom ventures Ltd signed a MoU

2008
-Max India signs agreement with UK firm for health insurance biz

2012
-Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders.
-Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-


2013
- Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders.
-Ajanta Pharma has announces bonus in the ratio of 1:2

2014
-Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders

2015
-Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules
-Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market
-Fortune India presents award to Ajanta Pharma
-Ajanta Pharma gets approvals for 3 ANDA's
-Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2

2017
-Ajanta Pharma gets USFDA nod for Duloxetine Hydrochloride.
-Ajanta Pharma launches Eletriptan Hydrobromide Tablets.
-Ajanta Pharma launches Clonidine Hydrochloride Extended Release Tablets in US.
-Inaugurated & commissioned 1st phase at a New Facility in Guwahati, Assam, India
- Dahej facility receives successful US FDA approval.


2018
-Top Export Performer Award' by the Federation of Indian Export Organisations.
-Commissioned Ajanta's 1st ever Derma facility in Guwahati.

2019
-Ajanta Pharma USA Inc. (APUI) received DIANA award for ‘Best Overall Generic Manufacturer’ in less than $100 mn.
-New manufacturing facility for oral solid inaugurated at Pithampur.

2020
-Ajanta’s 1st Sterile Eye Drop Production Unit commissioned at Guwahati Facility.

2021
-Listed in Fortune 500 list of Indian companies Ranked 379th in Revenue Generation (Dec 2021).

2022

-The Company has issued Bonus Shares in the Ratio of 1:2.
-Ajanta Pharma awarded 'India's Best Managed Companies' for 2022 by Deloitte.
-Ajanta wins 'Maharashtra State Best Employer Brand Awards 2022' in Pharma sector
-Ajanta wins Excellence in Packaging Developed in India & Packaging Team of the Year at India Packaging Awards 2022

2023

The Company has infomed that, in its meeting scheduled on 10/03/2023 ,inter alia, to consider and approve the proposal for buyback of the equity shares of the Company and matters related / incidental thereto.


-Ajanta wins 'Outstanding Export Performance Award' from Pharmexcil in 'Formulation' category


-Ajanta wins 'Excellence in Pharma Supply Chain Management

- Ajanta wins Times Ascent Global Best Employer Brands 2023

2024

-Ajanta is Great Place To Work-Certified in India for the 2nd year in a row

-Yogesh & Rajesh Agrawal (MD & Jt. MD) recognised as 'Next Gen Leaders of the Year 2023' by Hurun India
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X